PortfoliosLab logoPortfoliosLab logo
PSG.DE vs. ARCC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PSG.DE vs. ARCC - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in PharmaSGP Holding SE (PSG.DE) and Ares Capital Corporation (ARCC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

PSG.DE is traded in EUR, while ARCC is traded in USD. To make them comparable, the ARCC values have been converted to EUR using the latest available exchange rates.

Returns By Period


PSG.DE

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*

ARCC

1D
-0.79%
1M
5.70%
6M
-2.78%
YTD
1.71%
1Y
-8.24%
3Y*
7.90%
5Y*
9.46%
10Y*
12.04%
ALL TIME*
13.20%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PSG.DE vs. ARCC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
PSG.DE
PharmaSGP Holding SE
0.00%16.21%18.09%-13.86%9.74%-5.00%-18.75%
ARCC
Ares Capital Corporation
1.71%-10.93%27.68%16.43%2.12%46.32%8.65%

Correlation

The correlation between PSG.DE and ARCC is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

-0.03

Correlation (5Y)
Calculated over the trailing 5-year period

-0.04

Correlation (All Time)
Calculated using the full available price history since Jun 19, 2020

-0.01

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PSG.DE vs. ARCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSG.DE

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


ARCC
ARCC Risk / Return Rank: 2323
Overall Rank
ARCC Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
ARCC Sortino Ratio Rank: 2020
Sortino Ratio Rank
ARCC Omega Ratio Rank: 2121
Omega Ratio Rank
ARCC Calmar Ratio Rank: 2626
Calmar Ratio Rank
ARCC Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSG.DE vs. ARCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PharmaSGP Holding SE (PSG.DE) and Ares Capital Corporation (ARCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PSG.DEARCCDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.94

Calmar ratioReturn relative to maximum drawdown

-0.46

Martin ratioReturn relative to average drawdown

-0.76

PSG.DE vs. ARCC - Sharpe Ratio Comparison


Loading charts...

Drawdowns

PSG.DE vs. ARCC - Drawdown Comparison


Loading charts...

Drawdown Indicators


PSG.DEARCCDifference

Max Drawdown

Largest peak-to-trough decline

-73.77%

Max Drawdown (1Y)

Largest decline over 1 year

-17.91%

Max Drawdown (3Y)

Largest decline over 3 years

-25.98%

Max Drawdown (5Y)

Largest decline over 5 years

-25.98%

Max Drawdown (10Y)

Largest decline over 10 years

-56.16%

Current Drawdown

Current decline from peak

-16.76%

Average Drawdown

Average peak-to-trough decline

-10.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.37%

Volatility

PSG.DE vs. ARCC - Volatility Comparison


Loading charts...

Volatility by Period


PSG.DEARCCDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.81%

Volatility (6M)

Calculated over the trailing 6-month period

14.95%

Volatility (1Y)

Calculated over the trailing 1-year period

19.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.03%

Dividends

PSG.DE vs. ARCC - Dividend Comparison

PSG.DE has not paid dividends to shareholders, while ARCC's dividend yield for the trailing twelve months is around 10.12%.


PositionTTM20252024202320222021202020192018201720162015
ARCC
Ares Capital Corporation
10.12%9.49%8.77%9.59%10.12%7.65%9.47%9.01%9.88%9.67%9.22%11.02%
PSG.DE
PharmaSGP Holding SE
0.00%0.17%5.44%2.18%1.69%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PSG.DE vs. ARCC - Financials Comparison

This section allows you to compare key financial metrics between PharmaSGP Holding SE and Ares Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. PSG.DE values in EUR, ARCC values in USD

Frequently Asked Questions


PSG.DE and ARCC have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for PSG.DE and ARCC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer